Daphne Quimi - 12 Sep 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Director
Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
12 Sep 2024
Net transactions value
+$7,657
Form type
4
Filing time
16 Sep 2024, 16:18:18 UTC
Previous filing
21 Jun 2024
Next filing
09 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Purchase $7,657 +5,000 $1.53 5,000 12 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.525 to $1.54. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.